2001
DOI: 10.1007/s007750100242
|View full text |Cite
|
Sign up to set email alerts
|

Relaxometric characterization of human hemalbumin

Abstract: Hemalbumin [i.e., Fe(III)-protoporphyrin IX-human serum albumin; Fe(III)heme-HSA] is an important intermediate in the recovery of heme iron following hemolysis. Relaxometric data are consistent with the occurrence of a hexacoordinated high-spin Fe(III) center with no water in the inner coordination sphere. The relatively high relaxation enhancement observed for an aqueous solution of Fe(III)heme-HSA (r1p=4.8 mM(-1)s(-1) at 20 MHz, pH 7, and 25 C) is ascribed to the occurrence of a strong contribution from wate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
56
2

Year Published

2002
2002
2011
2011

Publication Types

Select...
5
1

Relationship

4
2

Authors

Journals

citations
Cited by 35 publications
(60 citation statements)
references
References 20 publications
2
56
2
Order By: Relevance
“…Furthermore, this behavior, which underlies the occurrence of multiple conformations of iron(II) heme-HSA, may have great impact on the function of heme-HSA as a metabolite and drug transporter, since this proton-linked modulation is reflected in its capability of interacting with molecules circulating in the bloodstream, as previously demonstrated [3,8,20,22,[29][30][31][32]. Therefore, HSA, not only acting as a heme carrier but also displaying transient heme-based properties, represents a case for ''chronosteric effects'' [62], which opens the scenario toward the possibility of a time-and metabolite-dependent multiplicity of roles for HSA.…”
Section: Discussionmentioning
confidence: 88%
See 1 more Smart Citation
“…Furthermore, this behavior, which underlies the occurrence of multiple conformations of iron(II) heme-HSA, may have great impact on the function of heme-HSA as a metabolite and drug transporter, since this proton-linked modulation is reflected in its capability of interacting with molecules circulating in the bloodstream, as previously demonstrated [3,8,20,22,[29][30][31][32]. Therefore, HSA, not only acting as a heme carrier but also displaying transient heme-based properties, represents a case for ''chronosteric effects'' [62], which opens the scenario toward the possibility of a time-and metabolite-dependent multiplicity of roles for HSA.…”
Section: Discussionmentioning
confidence: 88%
“…At pH [ 8.0 and in the absence of ligands, HSA exhibits the basic form, which is characterized by a high affinity for some ligands (e.g., heme). Ligands that bind with the highest affinity to one of the conformational states may allosterically modulate the HSA transition [3,8,20,22,[29][30][31][32].…”
Section: Introductionmentioning
confidence: 99%
“…Heme-HSA was prepared by adding the appropriate volume of the stock heme solution (i.e., 1.2 9 10 -2 M heme in 1.0 9 10 -1 M NaOH) to the 1.0 9 10 -3 M HSA solution (1.0 9 10 -1 M phosphate buffer, pH 7.0) to obtain a final heme-HSA concentration ranging between 5.0 9 10 -6 and 1.0 9 10 -3 M. The heme to HSA ratio ranged between 1:10 and 9:10. The excess of HSA ensured that the heme was bound to the HSA primary binding site only [11]. The 1.0 9 10 -1 M myristate solution was prepared by adding 1.0 9 10 -4 mol sodium myristate to 1.0 ml of 1.0 9 10 -1 M NaOH.…”
Section: Methodsmentioning
confidence: 99%
“…The intensity of the signal is proportional to the magnetization at the end of the evolution interval [35]. The reproducibility in T 1 measurements was ±0.5% [11]. The temperature was controlled by a Stelar VTC-91 airflow heater and checked in the sample cavity with a mercury thermometer.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation